Showing results (71-80 of 148) with videos related to
Sort By:
Pageof 15
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2005
HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trialBradford N Bartholow, Susan Buchbinder, Connie Celum, et al.Plos One|January 1, 2016
Sexual Behavior and Network Characteristics and Their Association with Bacterial Sexually Transmitted Infections among Black Men Who Have Sex with Men in the United StatesHyman M Scott, Risha Irvin, Leo Wilton, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 alleleGuido Ferrari, Wesley Neal, Janet Ottinger, et al.AIDS (London, England)|April 25, 2009
Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with menPeter V Chin-Hong, Marla Husnik, Ross D Cranston, et al.The Journal of Infectious Diseases|November 20, 2004
Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE studyPeter V Chin-Hong, Eric Vittinghoff, Ross D Cranston, et al.AIDS (London, England)|August 24, 2017
Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomenMonica Gandhi, Pamela M Murnane, Peter Bacchetti, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC StudyAlbert Y Liu, Eric Vittinghoff, Patricia von Felten, et al.AIDS (London, England)|March 25, 2020
Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxisEric C Tang, Eric Vittinghoff, Susan S Philip, et al.Journal of Virology|November 27, 2004
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infectionMaureen P Martin, Michael M Lederman, Holli B Hutcheson, et al.Nature Genetics|July 23, 2002
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDSMaureen P Martin, Xiaojiang Gao, Jeong-Hee Lee, et al.Pageof 15